XML 39 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders' Equity (Tables)
3 Months Ended
Sep. 30, 2022
Stockholders' Equity  
Schedule of stock-based compensation expense in the consolidated statements of operations

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

Three Months Ended September 30, 

    

2021

    

2022

Cost of goods sold

$

206

$

216

Selling, general and administrative

6,767

6,840

Research and development

140

121

Stock-based compensation expense

$

7,113

$

7,177

Schedule of stock option activity

Weighted

Average

Weighted-Average

Aggregate

Number of

Exercise

Remaining Contractual

Intrinsic Value

    

Options

    

Price

    

Term

    

(in thousands)

Outstanding at June 30, 2022

 

110,645

 

$

82.43

 

Granted

 

Exercised

 

(2,919)

66.46

Expired or forfeited

 

(1,408)

80.45

Outstanding at September 30, 2022

 

106,318

82.90

6.1 years

$

162

Exercisable at September 30, 2022

66,027

77.14

 

4.5 years

$

162

Schedule of stock option activity

Weighted-

Average

    

Shares

    

Fair Value

Nonvested at June 30, 2022

 

427,447

$

90.17

Granted

 

324,224

89.25

Vested

 

(286,119)

97.22

Forfeited

 

(11,420)

88.87

Nonvested at September 30, 2022

 

454,132

$

85.10